Juvenile dermatomyositis calcifications selectively displayed markers of bone formation

Arthritis Care and Research

Volumn 61, Issue 4, 2009, Pages 501-508

  Urganus, Annette L ^a   Zhao, Yong Dong ^a   Pachman, Lauren M ^b,c  

^a Children's Memorial Research Center   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; BONE SIALOPROTEIN; DENTIN MATRIX PROTEIN 1; DENTIN PHOSPHOPROTEIN; GLYCOPROTEIN; MATRIX EXTRACELLULAR PHOSPHOGLYCOPROTEIN; MATRIX GLA PROTEIN; OSTEOCALCIN; OSTEONECTIN; OSTEOPONTIN; SMALL INTEGRIN BINDING LIGAND N LINKED GLYCOPROTEIN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE DEVELOPMENT; CASE REPORT; CELLULAR DISTRIBUTION; CHILD; CONNECTIVE TISSUE; DERMATOMYOSITIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JUVENILE DERMATOMYOSITIS; OSSIFICATION; SCHOOL CHILD; SOFT TISSUE CALCIFICATION;

ACID PHOSPHATASE; ADOLESCENT; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; CALCINOSIS; CALCIUM-BINDING PROTEINS; CHILD; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DERMATOMYOSITIS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; INTEGRIN-BINDING SIALOPROTEIN; ISOENZYMES; OSTEOBLASTS; OSTEOCALCIN; OSTEOCLASTS; OSTEOGENESIS; OSTEONECTIN; OSTEOPONTIN; PHOSPHOPROTEINS; SIALOGLYCOPROTEINS;

EID: 65249116366     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.24391     Document Type: Article

References (49)

1. Pachman LM, Lipton R, Ramsey-Goldman R, Shamiyeh E, Abbott K, Mendez EP, et al. History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry. Arthritis Rheum 2005;53:166-72.
2. Banker BQ, Victor M. Dermatomyositis (systemic angiopathy) of childhood. Medicine (Baltimore) 1966;45:261-89.
3. Rider LG. Calcinosis in juvenile dermatomyositis: pathogenesis and current therapies. Pediatr Rheumatol Online J 2003. URL: http://www. pedrheumonlinejournal.org/april/ calinosis.html.
4. Pachman LM, Abbott K, Sinacore JM, Amoruso L, Dyer A, Lipton R, et al. Duration of illness is an important variable for untreated children with juvenile dermatomyositis. J Pediatr 2006;148:247-53.
5. Pachman LM, Veis A, Stock S, Abbott K, Vicari F, Patel P, et al. Composition of calcifications in children with juvenile dermatomyositis: association with chronic cutaneous inflammation. Arthritis Rheum 2006;54:3345-50.
6. Davies CA, Jeziorska M, Freemont AJ, Herrick AL. Expression of osteonectin and matrix Gla protein in scleroderma patients with and without calcinosis. Rheumatology (Oxford) 2006;45: 1349-55.
7. Rajamannan NM, Nealis TB, Subramaniam M, Pandya S, Stock SR, Ignatiev CI, et al. Calcified rheumatic valve neoangiogenesis is associated with vascular endothelial growth factor expression and osteoblast-like bone formation. Circulation 2005;111:3296-301.
8. Qin C, Baba O, Butler WT. Post-translational modifications of sibling proteins and their roles in osteogenesis and dentinogenesis. Crit Rev Oral Biol Med 2004;15:126-36.
9. Fisher LW, Fedarko NS. Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins. Connect Tissue Res 2003;44 Suppl 1:33-40.
10. Brekken RA, Sage EH. SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol 2001; 19:816-27.
11. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997;386:78-81.
12. Lian JB, Pachman LM, Gundberg CM, Partridge RE, Maryjowski MC. 7-carboxyglutamate excretion and calcinosis in juvenile dermatomyositis. Arthritis Rheum 1982;25:1094-100.
13. Lian JB, Skinner M, Glimcher MJ, Gallop P. The presence of γ-carboxyglutamic acid in the proteins associated with ectopic calcification. Biochem Biophys Res Commun 1976;73: 349-55.
14. Van Summeren MJ, Spliet WG, van Royen-Kerkhof A, Vermeer C, Lilien M, Kuis W, et al. Calcinosis in juvenile dermatomyositis: a possible role for the vitamin K-dependent protein matrix Gla protein. Rheumatology (Oxford) 2008;47: 267-71.
15. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
16. Bode RK, Klein-Gitelman MS, Miller ML, Lechman TS, Pachman LM. Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence. Arthritis Rheum 2003;49:7-15.
17. Bouma G, Oudkerk Pool M, Scharenberg JG, Kolkman JJ, von Blomberg BM, Scheper RJ, et al. Differences in the intrinsic capacity of peripheral blood mononuclear cells to produce tumor necrosis factor α and β in patients with inflammatory bowel disease and healthy controls. Scand J Gastroenterol 1995;30:1095-100.
18. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39:225-35.
19. Taylor CR, Shi SR. Antigen retrieval technique for immunohistochemistry: principles, protocols, and further development. In: Lloyd RV, editor. Morphology methods: cell and molecular biology techniques. Totowa (NJ): Humana; 2001. p. 239-65.
20. Zhao Y, Fedczyna TO, McVicker V, Caliendo J, Li H, Pachman LM. Apoptosis in the skeletal muscle of untreated children with juvenile dermatomyositis: impact of duration of untreated disease. Clin Immunol 2007;125:165-7.
21. Lloyd RV. Laser capture microdissection: prinicples and applications. In: Lloyd RV, editor. Morphology methods: cell and molecular biology techniques. Totowa (NJ): Humana; 2001. p. 23.
22. Kawaguchi J. Generation of osteoblasts and chondrocytes from embryonic stem cells. In: Turksen K, editor. Methods in molecular biology. 2nd ed. Totowa (NJ): Humana; 2006.
23. Schett G, Tuerk B. Bone histomorphometry in arthritis models. In: Cope AP, editor. Methods in molecular medicine. Totowa (NJ): Humana; 2007. p. 269-83.
24. Bellahcene A, Castronovo V, Ogbureke KU, Fisher LW, Fedarko NS. Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer. Nat Rev Cancer 2008;8:212-26.
25. Scatena M, Liaw L, Giachelli CM. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 2007;27:2302-9.
26. Denhardt DT, Guo X. Osteopontin: a protein with diverse functions. FASEB J 1993;7:1475-82.
27. Pachman LM. Myositis. In: Isenberg DA, Miller II, John J, editors. Adolescent rheumatology. New York: Informa Healthcare; 1999. p. 127-46.
28. Weber GF, Zawaideh S, Hikita S, Kumar VA, Cantor H, Ashkar S. Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation. J Leukoc Biol 2002;72:752-61.
29. Uzel G, Pachman LM. Cytokines in juvenile dermatomyositis pathophysiology: potential and challenge. Curr Opin Rheumatol 2003;15:691-7.
30. Fedczyna TO, Lutz J, Pachman LM. Expression of TNFα by muscle fibers in biopsies from children with untreated juvenile dermatomyositis: association with the TNFα-308A allele. Clin Immunol 2001;100:236-9.
31. Lee SK, Lorenzo J. Cytokines regulating osteoclast formation and function. Curr Opin Rheumatol 2006;18:411-8.
32. Valverde P, Tu Q, Chen J. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically. J Bone Miner Res 2005;20:1669-79.
33. Gordon JA, Tye CE, Sampaio AV, Underhill TM, Hunter GK, Goldberg HA. Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro. Bone 2007;41:462-73.
34. Narayanan K, Ramachandran A, Hao J, He G, Park KW, Cho M, et al. Dual functional roles of dentin matrix protein 1: implications in biomineralization and gene transcription by activation of intracellular Ca2+ store. J Biol Chem 2003;278: 17500-8.
35. Qin C, D'Souza R, Feng JQ. Dentin matrix protein 1 (DMP1): new and important roles for biomineralization and phosphate homeostasis. J Dent Res 2007;86:1134-41.
36. Stock S, Ignatiev K, Lee P, Abbott K, Pachman L. Pathological calcification in juvenile dermatomyositis (JDM): microCT and synchrotron x-ray diffraction reveal hydroxyapatite with varied microstructures. Connect Tissue Res 2004;45:248-56.
37. Silva TA, Lara VS, Silva JS, Garlet GP, Butler WT, Cunha FQ. Dentin sialoprotein and phosphoprotein induce neutrophil recruitment: a mechanism dependent on IL-1β, TNF-β, and CXC chemokines. Calcif Tissue Int 2004;74:532-41.
38. Silva TA, Lara VS, Silva JS, Oliveira SH, Butler WT, Cunha FQ. Macrophages and mast cells control the neutrophil migration induced by dentin proteins. J Dent Res 2005;84: 79-83.
39. Gowen LC, Petersen DN, Mansolf AL, Qi H, Stock JL, Tkalcevic GT, et al. Targeted disruption of the osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass. J Biol Chem 2003;278:1998-2007.
40. Six N, Septier D, Chaussain-Miller C, Blacher R, DenBesten P, Goldberg M. Dentonin, a MEPE fragment, initiates pulphealing response to injury. J Dent Res 2007;86:780-5.
41. Porter PL, Sage EH, Lane TF, Funk SE, Gown AM. Distribution of SPARC in normal and neoplastic human tissue. J Histochem Cytochem 1995;43:791-800.
42. Ducy P. Cbfa1: a molecular switch in osteoblast biology. Dev Dyn 2000;219:461-71.
43. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, et al. Increased bone formation in osteocalcin-deficient mice. Nature 1996;382:448-52.
44. Boskey AL, Gadaleta S, Gundberg C, Doty SB, Ducy P, Karsenty G. Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 1998;23:187-96.
45. Jahnen-Dechent W, Schafer C, Ketteler M, McKee MD. Mineral chaperones: a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification. J Mol Med 2008;86:379-89.
46. Marhaug G, Shah V, Shroff R, Varsani H, Wedderburn LR, Pilkington CA, et al. Age-dependent inhibition of ectopic calcification: a possible role for fetuin-A and osteopontin in patients with juvenile dermatomyositis with calcinosis. Rheumatology (Oxford) 2008;47:1031-7.
47. Christen-Zaech S, Seshadri R, Sundberg J, Paller AS, Pachman LM. Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis. Arthritis Rheum 2008;58:571-6.
48. Hallmann R, Horn N, Selg M, Wendler O, Pausch F, Sorokin LM. Expression and function of laminins in the embryonic and mature vasculature. Physiol Rev 2005;85:979-1000.
49. Sosnoski DM, Gay CV. Evaluation of bone-derived and marrow-derived vascular endothelial cells by microarray analysis. J Cell Biochem 2007;102:463-72.